Target type: biologicalprocess
The process in which the anatomical structures of a limb are generated and organized. A limb is a paired appendage of a tetrapod used for locomotion or grasping. [UBERON:0002101]
Limb morphogenesis is a complex biological process involving the coordinated development of skeletal, muscular, vascular, and nervous structures to form functional limbs. This process begins during embryonic development and involves a series of precisely orchestrated events.
**1. Limb Bud Formation:**
- The first step is the formation of limb buds, which are small, bud-like structures that arise from the lateral plate mesoderm.
- These buds are induced by signals from the underlying somites and the apical ectodermal ridge (AER).
- The AER is a thickened region of ectoderm at the distal tip of the limb bud, and it plays a crucial role in limb outgrowth and patterning.
**2. Limb Outgrowth and Patterning:**
- The limb buds grow and elongate, driven by the proliferation of mesenchymal cells within the bud.
- The AER secretes signaling molecules, such as fibroblast growth factors (FGFs), which promote cell proliferation and maintain the growth zone of the limb bud.
- The zone of polarizing activity (ZPA), located at the posterior margin of the limb bud, secretes retinoic acid (RA) and sonic hedgehog (Shh) signaling molecules.
- These signals establish the anterior-posterior (A-P) axis of the limb and pattern the development of digits.
**3. Skeletal Development:**
- The mesenchymal cells within the limb bud differentiate into chondrocytes, which form the cartilage model of the skeleton.
- The cartilage model is subsequently replaced by bone through endochondral ossification.
- The pattern of skeletal elements, including the stylopod, zeugopod, and autopod, is determined by the interplay of signaling molecules from the AER and ZPA.
**4. Muscular Development:**
- Muscle precursor cells, known as myoblasts, migrate from the somites into the limb bud.
- Myoblasts fuse to form multinucleated myotubes, which differentiate into mature muscle fibers.
- The pattern of muscle development is influenced by signaling molecules from the AER and ZPA, as well as by interactions with the developing skeleton.
**5. Vascular Development:**
- Blood vessels develop within the limb bud, providing oxygen and nutrients for the growing tissues.
- Angiogenesis, the formation of new blood vessels, is regulated by signaling molecules from the AER, ZPA, and other tissues within the limb.
**6. Nervous Development:**
- Nerves also extend into the limb bud, providing innervation to the developing muscles and other tissues.
- Nerve growth factors (NGFs) and other guidance cues regulate the growth and pathfinding of axons.
**7. Limb Rotation:**
- In tetrapods, the limbs undergo a rotation during development, resulting in the characteristic orientation of the limbs in the body.
- The rotation is driven by changes in cell shape and the rearrangement of tissues within the limb bud.
**8. Limb Refinement:**
- The final stages of limb morphogenesis involve the refinement of the limb structures, including the shaping of the digits, the formation of joints, and the differentiation of specific muscle types.
- This process is regulated by a complex interplay of signaling molecules, transcription factors, and epigenetic modifications.
Limb morphogenesis is a highly regulated process that involves a complex interplay of signaling molecules, transcription factors, and cell-cell interactions. Disruptions in these processes can lead to birth defects affecting limb development.'
"
Protein | Definition | Taxonomy |
---|---|---|
Bcl-2 homologous antagonist/killer | A Bcl-2 homologous antagonist/killer that is encoded in the genome of human. [PRO:WCB, UniProtKB:Q16611] | Homo sapiens (human) |
Aspartyl/asparaginyl beta-hydroxylase | An aspartyl/asparaginyl beta-hydroxylase that is encoded in the genome of human. [PRO:DNx, UniProtKB:Q12797] | Homo sapiens (human) |
Compound | Definition | Classes | Roles |
---|---|---|---|
gossypol | Gossypol: A dimeric sesquiterpene found in cottonseed (GOSSYPIUM). The (-) isomer is active as a male contraceptive (CONTRACEPTIVE AGENTS, MALE) whereas toxic symptoms are associated with the (+) isomer. | ||
2,4-pyridinedicarboxylic acid | lutidinic acid : A pyridinedicarboxylic acid carrying carboxy groups at positions 2 and 4. | pyridinedicarboxylic acid | |
alexidine dihydrchloride | |||
6-n-tridecylsalicylic acid | 6-n-tridecylsalicylic acid: structure given in first source | hydroxybenzoic acid | |
5,6-dehydrokawain | 5,6-dehydrokawain: from Alpinia speciosa rhizoma; RN given for cpd without isomeric designation; structure given in first source | 2-pyranones; aromatic ether | |
bleomycin | bleomycin | antineoplastic agent; metabolite | |
tubacin | tubacin: inhibits histone deacetylase 6; structure in first source | 1,3-oxazoles | |
belinostat | hydroxamic acid; olefinic compound; sulfonamide | antineoplastic agent; EC 3.5.1.98 (histone deacetylase) inhibitor | |
midostaurin | midostaurin : An organic heterooctacyclic compound that is the N-benzoyl derivative of staurosporine. | benzamides; gamma-lactam; indolocarbazole; organic heterooctacyclic compound | antineoplastic agent; EC 2.7.11.13 (protein kinase C) inhibitor |
abt-737 | aromatic amine; aryl sulfide; biphenyls; C-nitro compound; monochlorobenzenes; N-arylpiperazine; N-sulfonylcarboxamide; secondary amino compound; tertiary amino compound | anti-allergic agent; anti-inflammatory agent; antineoplastic agent; apoptosis inducer; B-cell lymphoma 2 inhibitor | |
navitoclax | aryl sulfide; monochlorobenzenes; morpholines; N-sulfonylcarboxamide; organofluorine compound; piperazines; secondary amino compound; sulfone; tertiary amino compound | antineoplastic agent; apoptosis inducer; B-cell lymphoma 2 inhibitor | |
plx4032 | aromatic ketone; difluorobenzene; monochlorobenzenes; pyrrolopyridine; sulfonamide | antineoplastic agent; B-Raf inhibitor | |
meiogynin a | meiogynin A: from the bark of Meiogyne cylindrocarpa; structure in first source | ||
abt-199 | venetoclax : A member of the class of pyrrolopyridines that is a potent inhibitor of the antiapoptotic protein B-cell lymphoma 2. It is used for treamtment of chronic lymphocytic leukemia with 17p deletion. venetoclax: A BCL-2 inhibitor with antineoplastic activity that is used in the treatment of CHRONIC LYMPHOCYTIC LEUKEMIA associated with chromosome 17p deletion; structure in first source. | aromatic ether; C-nitro compound; monochlorobenzenes; N-alkylpiperazine; N-arylpiperazine; N-sulfonylcarboxamide; oxanes; pyrrolopyridine | antineoplastic agent; apoptosis inducer; B-cell lymphoma 2 inhibitor |
jy-1-106 | JY-1-106: a BH3 alpha-helix mimetic that functions as a pan-Bcl-2 inhibitor; structure in first source |